Read More Pharma Industry News Dynacure’s centronuclear myopathies drug DYN101 gets FDA orphan drug designation French pharma company Dynacure has secured orphan drug designation for its investigational antisense drug DYN101 from the US… bypharmanewsdailyAugust 10, 2019
